These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37396311)

  • 1. PP4R1 Accelerates Cell Growth and Proliferation in HepG2 Hepatocellular Carcinoma [Retraction].
    Onco Targets Ther; 2023; 16():481-482. PubMed ID: 37396311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PP4R1 accelerates cell growth and proliferation in HepG2 hepatocellular carcinoma.
    Wu G; Ma Z; Qian J; Liu B
    Onco Targets Ther; 2015; 8():2067-74. PubMed ID: 26300649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PP4R1 Accelerates Cell Growth and Proliferation in HepG2 Hepatocellular Carcinoma [Expression of Concern].
    Onco Targets Ther; 2020; 13():6857. PubMed ID: 32764977
    [No Abstract]   [Full Text] [Related]  

  • 4. MiR-144 Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
    Onco Targets Ther; 2021; 14():3295-3296. PubMed ID: 34040393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-212 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induces Apoptosis by Targeting FOXA1 [Retraction].
    Onco Targets Ther; 2022; 15():849-850. PubMed ID: 35975009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-502-3P Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting
    Onco Targets Ther; 2021; 14():3177. PubMed ID: 34040385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of SLP-2 in Hepatocellular Carcinoma Tissues and Its Regulation in Cancer Cell Proliferation, Migration, and EMT [Retraction].
    Onco Targets Ther; 2022; 15():869-870. PubMed ID: 36003327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA UCA1 Accelerates Nasopharyngeal Carcinoma Cell Progression by Modulating miR-124-3p/ITGB1 Axis [Retraction].
    Onco Targets Ther; 2022; 15():117-118. PubMed ID: 35115785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NEAT1 Promotes Proliferation, Migration and Invasion via Regulating miR-296-5p/CNN2 Axis in Hepatocellular Carcinoma Cells [Retraction].
    Onco Targets Ther; 2021; 14():5095-5096. PubMed ID: 34707367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction].
    Onco Targets Ther; 2021; 14():123. PubMed ID: 33447053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression [Retraction].
    Onco Targets Ther; 2022; 15():145-146. PubMed ID: 35173447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Acetone Indigo Red Dehydrating Agent IF203 Induces HepG2 Cell Death Through Cell Cycle Arrest, Autophagy and Apoptosis [Retraction].
    Onco Targets Ther; 2020; 13():9955. PubMed ID: 33116580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction].
    Onco Targets Ther; 2023; 16():281-282. PubMed ID: 37113686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Retraction].
    Onco Targets Ther; 2022; 15():871-872. PubMed ID: 36033902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis [Retraction].
    Onco Targets Ther; 2021; 14():5419-5420. PubMed ID: 34916805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo [Retraction].
    Onco Targets Ther; 2023; 16():309-310. PubMed ID: 37192931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p [Retraction].
    Onco Targets Ther; 2022; 15():1389-1390. PubMed ID: 36419865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways [Retraction].
    Onco Targets Ther; 2024; 17():305-306. PubMed ID: 38617089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLPH Accelerates the Epithelial-Mesenchymal Transition in Prostate Cancer [Retraction].
    Onco Targets Ther; 2023; 16():1051-1052. PubMed ID: 38116521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of LINC01296 in Pan-Cancers and the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation [Retraction].
    Onco Targets Ther; 2020; 13():2525. PubMed ID: 32273722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.